2026 3rd Public CDMO Strategic Development and Biotech Production Support Program for Animal Cell-based Vaccines
- Deadline
- 마감일 원문 확인
Supports manufacturing process optimization and scale-up using GMP facilities, cell bank (MCB/WCB) manufacturing, production of preclinical/clinical trial samples, and quality/stability testing.
3-second summary
- Support Content: Manufacturing process optimization and scale-up support
- Support Content: MCB/WCB cell bank manufacturing support
- Support Content: Preclinical/clinical trial sample production support
- Support Content: Quality and stability testing support
Recommended for
- Recommended for biotech company CEOs who need GMP process optimization, scale-up, or clinical sample production for animal cell-based vaccine development.
Frequently asked questions
How do I apply?
Applications follow the official program notice, which is in Korean. See the source link for the method and receiving office; Beaconoi can prepare an English draft for your review.
Last updated · Source: official program notice
※ Program information is compiled from each institution’s public sources; actual eligibility, amounts and deadlines may change. Always verify against the official notice (in Korean) before applying.